• Baleiras Couto, M.M., Eijsma, B., Hofstra, H., Huis in't Veld, J.H. and Van der Vossen, J.M. (1996) Evaluation of molecular typing techniques to assign genetic diversity among Saccharomyces cerevisiae strains. Applied and Environmental Microbiology 62, 4146.
  • Barnett, J.A. (1992) The taxonomy of the genus Saccharomyces Meyen ex Reess: a short review for non taxonomists. Yeast 8, 123.
  • Bassetti, S., Frei, R. and Zimmerli, W. (1998) Fungemia with Saccharomyces cerevisiae after treatment with Saccharomyces boulardii. American Journal of Medicine 105, 7172.
  • Briones, A.I., Ubeda, J. and Grando, M.S. (1996) Differentiation of Saccharomyces cerevisiae strains isolated from fermenting musts according to their karyotype patterns. International Journal of Food Microbiology 28, 369377.
  • Buts, J.P., Bernasconi, P., Vaerman, J.P. and Dive, C. (1990) Stimulation of secretory IgA and secretory component of immunglobolins in small intestine of rats treated with Saccharomyces boulardii. Digestive Diseases and Sciences 35, 251256.
  • Caetano, J.A., Parames, M.T., Babo, M.J., Santos, A., Ferreira, A.B., Freitas, A.A., Coelho, M.R. and Mateus, A.M. (1986) Immunopharmacological effects of Saccharomyces boulardii in healthy human volunteers. International Journal of Immunopharmacology 8, 245259.
  • Cardinali, G. and Martini, A. (1994) Electrophoretic karyotypes ofauthentic strains of the sensu stricto group of the genus Saccharomyces. International Journal of Systematic Bacteriology 44, 791797.
  • Castagliuolo, I., LaMont, J.T., Nikulasson, S.T. and Pothoulakis, C. (1996) Saccharomyces boulardii protease inhibits Clostridium difficile toxin A effects in the rat ileum. Infection and Immunity 64, 52255232.
  • Ducluzeau, R. and Bensaada, M. (1982) Comperative effect of a single or continuous administration of Saccharomyces boulardii on the establishment of various strains of Candida in the digestive tract of gnotobiotic mice. Annales de Microbiologie 133, 491501.
  • Elmer, G.W. and McFarland, L.W. (1987) Suppression by Saccharomyces boulardii of toxigenic Clostridium difficile overgrowth after vancomycin treatment in hamsters. Antimicrobial Agents in Chemotherapy 31, 129131.
  • Hayford, A.E. and Jespersen, L. (1999) Characterization of Saccharomyces cerevisiae strains from spontaneously fermented maize dough by profiles of assimilation, chromosome polymorphism, PCR and MAL genotyping. Journal of Applied Microbiology 86, 284294.
  • Huffman, J.L., Molina, F.I. and Jong, S.-C. (1992) Authentication of ATCC strains in the Saccharomyces cerevisiae complex by PCR fingerprinting. Experimental Mycology 16, 316319.
  • Josepa, S., Guillamon, J.M. and Cano, J. (2000) PCR differentiation of Saccharomyces cerevisiae from Saccharomyces bayanus/Saccharomyces pastorianus using specific primers. FEMS Microbiology Letters 193, 255259.
  • Kimmey, M.B., Elmer, G.W., Surawicz, C.M. and McFarland, L.V. (1990) Prevention of further recurrences of Clostridium difficile colitis with Saccharomyces boulardii. Digestive Diseases and Sciences 35, 897901.
  • Kollaritsch, H., Holst, H., Grobara, P. and Wiedermann, G. (1993) [Prevention of traveller's diarrhea with Saccharomyces boulardii. Results of a placebo controlled double-blind study.] Fortschritte der Medizin 30, 152156.
  • Kunze, G., Kunze, I., Barner, A. and Schulz, R. (1993) Genetical and biochemical characterization of Saccharomyces cerevisiae industrial strains. Fresenius' Journal of Analytical Chemistry 346, 868871.
  • McFarland, L.V. (1996) Saccharomyces boulardii is not Saccharomyces cerevisiae. Clinical Infectious Disease 22, 200201.
  • McFarland, L.V., Surawicz, C.M., Greenberg, R.N., Fekety, R., Elmer, G.W., Moyer, K.A., Melcher, S.A., Bowen, K.E., Cox, J.L. and Noorani, Z.A. (1994) A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. Journal of the American Medical Association 271, 19131918.
  • Mitterdorfer, G., Kneifel, W. and Viernstein, H. (2001) Utilization of prebiotic carbohydrates by yeasts of therapeutic relevance. Letters in Applied Microbiology 33, 251255.
  • Molnar, O., Messner, R., Prillinger, H., Stahl, U. and Slavikova, E. (1995) Genotypic identification of Saccharomyces species using random amplified polymorphic DNA analysis. Systematic and Applied Microbiology 18, 136145.
  • Mortimer, R.K., Game, J.C., Bell, M. and Contopoulou, C.R. (1990) Use of pulsed-field gel electrophoresis to study the chromosomes of Saccharomyces and other yeasts. Methods 1, 169179.
  • Piarroux, R., Millon, L., Bardonnet, K., Vagner, O. and Koenig, H. (1999) Are live Saccharomyces yeasts harmful to patients. Lancet 353, 18511852.
  • Pothoulakis, C., Kelly, C.P., Joshi, M.A., Gao, N., O'Keane, C.J., Castagliuolo, I. and Lamont, J.T. (1993) Saccharomyces boulardii inhibits Clostridium toxin A binding and enterotoxicity in rat ileum. Gastroenterology 104, 11081115.
  • Valente, P., De Gouveia, F.C., Lemos, G.A., Pimentel, D., Van Elsas, J.D., Mendonca-Hagler, L.C. and Hagler, A.N. (1996) PCR amplification of the rDNA internal transcribed spacer region for differentiation of Saccharomyces cultures. FEMS Microbiology Letters 137, 253256.
  • Vaughan-Martini, A. and Martini, A. (1998) Saccharomyces Meyeen ex Reess. In The Yeasts ed. Kurtzman, C.P. and Fell, J.W. Amsterdam: Elsevier.
  • Ward, P., Roy, D., Vincent, D. and Mondou, F. (1997) Rapid identification of commercial strains of Lactobacillus acidophilus group and Lactobacillus helveticus with the RAPD (Random amplified polymorphic DNA) technique. In Agriculture and Agri-Food, Book of AbstractsMontreal, Québec, Canada: Rosell Institute Inc.